Xiretsa
PrivateLast Round
Angel
Nov 18, 2024
Total Funding Raised
$355,000
Company Overview
Xiretsa operates in Healthcare & Life Sciences and is based in Santa Barbara, California. Its latest recorded funding round was an Angel round in November 2024.
Xiretsa is a biotechnology company that develops novel membrane-remodeling small-molecule antibiotics to combat drug-resistant bacterial and fungal infections.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xiretsa Comparables
Compare Xiretsa with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sun Pharma | 71% | |
| Shionogi & Co. | 70% | |
| APY Therapeutics | 56% |
For institutional investors. Book with your work email.
Xiretsa Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Nov 18, 2024 | ||||
| Grant | Feb 6, 2024 | ||||
| Grant | Mar 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Xiretsa Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| INCATE | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 18, 2024
$75K raised in an angel round.
- Feb 6, 2024
$269K grant received from INCATE.
For institutional investors. Book with your work email.
Xiretsa Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Xiretsa's valuation, stock price, and market status.
Is Xiretsa a public or private company?
Xiretsa is a private company.
What is the current stock price of Xiretsa?
Xiretsa is a private company, so its shares have no public market price. Caplight tracks Xiretsa's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Xiretsa worth (valuation)?
Valuation information for Xiretsa is not publicly available.
Can I buy Xiretsa stock?
Xiretsa shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Xiretsa's last funding round?
Xiretsa's most recent funding round was Angel on November 18, 2024.
Who are the main investors in Xiretsa?
Key investors in Xiretsa include National Institute of Allergy and Infectious Diseases, INCATE.
Will Xiretsa IPO soon?
No public IPO plans have been announced for Xiretsa.
How can I track Xiretsa secondary market activity?
Caplight tracks bids, offers, and trades in Xiretsa's shares on secondary markets.